IP Library Granted Patent US 7,918,830
Granted Patent B2
US 7,918,830 · App. 12/123,301 · Granted Apr 5, 2011

Safety device for drug delivery devices and containers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,918,830
App. No.
12/123,301
Granted
Apr 5, 2011
Kind
B2
Abstract

A drug administration safety device having a label configured to be attached to a drug container such as a syringe or IV bag, an adhesive on the back face of the label, and a backing or substrate for holding the label and protecting the adhesive prior to the application of the label to the drug container. In one embodiment, the label includes a first drug name section in a first orientation, a second drug name section in a second orientation, a third drug name section in a third orientation, a drug concentration section, a variable information section, and a gradiation viewing section. The first orientation, second orientation, and third orientation are different from each other to enable a user to readily see the drug name regardless of the position and orientation of the drug container.

Claims (33)

1. A drug administration safety device comprising:

a single label configured to be attached to an operating room intravenous syringe containing a drug, said drug having a name including a plurality of letters, said drug being of a designated concentration, said single label including an interior surface and an exterior surface, said single label including:

(a) first drug name letters including the letters of the name of the drug, said first drug name letters readable when looking at said exterior surface, said first drug name letters being upright and positioned around part of a first circumferential section of the syringe when the syringe with the single label attached is viewed from a first position where a plunger of the syringe is below the label,

(b) second drug name letters including the letters of the name of the drug, said second drug name letters readable when looking at said exterior surface, said second drug name letters being upright and being positioned around part of a second circumferential section of the syringe when the syringe with the single label attached is viewed from a second position where the plunger of the syringe is above the label, said second position being different from said first position,

(c) third drug name letters including the letters of the name of the drug, said third drug name letters readable when looking at said exterior surface, said third drug name letters being upright when the syringe with the single label attached is viewed from a third position, said third position being different from said first position, and said third position being different from said second position,

(d) drug concentration letters and numbers indicating the designated concentration of the drug, and

(e) variable information letters and numbers indicating other information relating to the drug;

an adhesive on the interior surface of the single label; and

a backing for holding the single label and protecting the adhesive prior to the application of the single label to the syringe.

2. The drug administration safety device of claim 1 , wherein the single label includes fourth drug name letters including the letters of the name of the drug, said fourth drug name letters readable when looking at said exterior surface, said fourth drug name letters being upright when the syringe with the single label attached is viewed from the first position.

3. The drug administration safety device of claim 1 , wherein the single label includes fourth drug name letters including the letters of the name of the drug, said fourth drug name letters readable when looking at said exterior surface.

4. A drug container comprising:

an operating room intravenous syringe;

a drug contained within the syringe, said drug having a name including a plurality of letters, said drug being of a designated concentration; and

a single label attached to the syringe, said single label including an interior surface and an exterior surface, said single label including:

(a) first drug name letters including the letters of the name of the drug contained within the syringe, said first drug name letters readable when looking at said exterior surface, said first drug name letters being upright when the syringe is viewed from a first position where a plunger of the syringe is below the label, said first drug name letters being positioned around part of a first circumferential section of the syringe,

(b) second drug name letters including the letters of the name of the drug contained within the syringe, said second drug name letters readable when looking at said exterior surface, said second drug name letters being upright when the syringe is viewed from a second position where the plunger of the syringe is above the label, said second position being different from the first position, said second drug name letters being positioned around part of a second circumferential section of the syringe,

(c) third drug name letters including the letters of the name of the drug contained within the syringe, said third drug name letters readable when looking at said exterior surface, said third drug name letters being upright when the syringe is viewed from a third position, said third position being different from said first position, and said third position being different from said second position,

(d) drug concentration letters and numbers indicating the designated concentration of the drug contained within the syringe, and

(e) variable information letters and numbers indicating other information relating to the drug contained within the syringe.

5. The drug container of claim 4 , wherein the single label includes fourth drug name letters including the letters of the name of the drug contained within the syringe, said fourth drug name letters readable when looking at said exterior surface, said fourth drug name letters being upright when the syringe is viewed from the first position.

6. The drug container of claim 4 , wherein the single label includes a fourth drug name letter including the letters of the name of the drug contained within the syringe, said fourth drug name letters readable when looking at said exterior surface.

7. A drug container comprising:

an operating room intravenous syringe;

a drug contained within the syringe, said drug having a name including a plurality of letters, said drug being of a designated concentration; and

a single label attached to the syringe, said single label including an interior surface and an exterior surface, said single label including:

(a) first drug name letters including the letters of said name of the drug contained within the syringe, said first drug name letters readable when looking at said exterior surface, said first drug name letters being upright when the syringe is viewed from a first position where a plunger of the syringe is below the label and being upside down when the syringe is viewed from a second position where the plunger of the syringe is above the label, said second position being different from said first position, said first drug name letters being positioned around part of a first circumferential section of the syringe,

(b) second drug name letters including the letters of said name of the drug contained within the syringe, said second drug name letters readable when looking at said exterior surface, said second drug name letters being upright when the syringe is viewed from said second position and being upside down when the syringe is viewed from said first position, said second drug name letters being positioned around part of a second circumferential section of the syringe,

(c) third drug name letters including the letters of said name of the drug contained within the syringe, said third drug name letters readable when looking at said exterior surface, said third drug name letters being upright when the syringe is viewed from a third position, said third position being different from said first position, and said third position being different from said second position,

(d) drug concentration letters and numbers indicating the designated concentration of the drug contained within the syringe, and

(e) variable information letters and numbers indicating other information relating to the drug contained within the syringe.

8. The drug container of claim 7 , wherein the single label includes fourth drug name letters including said letters of the name of the drug contained within the syringe, said fourth drug name letters readable when looking at said exterior surface, said fourth drug name letters being upright when the syringe is viewed from the first position.

9. The drug container of claim 7 , wherein the single label includes a fourth drug name letters including said letters of the name of the drug contained within the syringe, said fourth drug name letters readable when looking at said exterior surface.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2021
From: RUNWAY ADVISORS, LLC
To: HIKMA PHARMACEUTICALS USA INC.
Reel/Frame 055270/0335 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2020
From: PHARMEDIUM SERVICE, LLC
To: RUNWAY ADVISORS, LLC
Reel/Frame 053646/0281 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS - SECOND LIEN Recorded Nov 11, 2015
From: CREDIT SUISSE AG
To: PHARMEDIUM SERVICES, LLC
Reel/Frame 037097/0493 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS - FIRST LIEN Recorded Nov 11, 2015
From: JPMORGAN CHASE BANK, N.A.
To: PHARMEDIUM SERVICES, LLC
Reel/Frame 037097/0514 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Aug 26, 2015
From: BANK OF MONTREAL
To: PHARMEDIUM SERVICES, LLC
Reel/Frame 036477/0200 →
NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS-FIRST LIEN Recorded Feb 20, 2014
From: PHARMEDIUM SERVICES, LLC
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 032301/0828 →
NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS - SECOND LIEN Recorded Feb 20, 2014
From: PHARMEDIUM SERVICES, LLC
To: CREDIT SUISSE AG
Reel/Frame 032302/0275 →
SECURITY AGREEMENT Recorded Dec 26, 2012
From: PHARMEDIUM SERVICES, LLC
To: BANK OF MONTREAL
Reel/Frame 029539/0528 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2008
From: LANGAN, AMY ELIZABETH; KRUZYNSKI, RICHARD JOHN; KOLLAR, JOHN ANTON; MIYAKE, PATRICIA LYNN; KRUK, MONIQUE LASAYRE; WAGNER, MARK FRANCIS
To: PHARMEDIUM SERVICES, LLC
Reel/Frame 021318/0546 →